ISPOR - And Then There Were Three; The Burgeoning Market Of Oral Medications Approved To Treat Multiple Sclerosis In The United States

Full Text

And Then There Were Three; The Burgeoning Market Of Oral Medications Approved To Treat Multiple Sclerosis In The United States

Abstract

Authors

B.H. Johnson

Back to Volume 17, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now